Mereo BioPharma Group Plc (MREO)
0.5651
-0.07
(-11.70%)
USD |
NASDAQ |
Jan 20, 16:00
0.58
+0.01
(+2.64%)
After-Hours: 04:06
Mereo BioPharma Group Market Cap: 89.85M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.854M |
| NuCana Plc | 13.36M |
| Autolus Therapeutics Plc | 377.92M |
| Bicycle Therapeutics Plc | 462.68M |
| Ultragenyx Pharmaceutical, Inc. | 2.183B |
Market Cap Related Metrics
| PS Ratio | 176.46 |
| Price to Book Value | 1.928 |
| Price | 0.5651 |
| Earnings Yield | -46.65% |